Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQXS5LO1W
Performance in the last:
Follow this Portfolio
1D 0.9 %
1W 3.9 %
2W 3.8 %
1M -1.9 %
3M -13.9 %
6M -12.0 %
9M -20.6 %
1Y -22.2 %
Alpha
-39.5%
Beta
0.75
sharpe-R
-0.73
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.12
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-16 06:55:13
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -26.12%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Week in the Equity asset class. The maximum number of assets that can be allocated in this strategy is 5.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
4
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
MPW Medical Properties Trust, Inc. Equity Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
MPW Medical Properties Trust, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • MPW
Assets Removed
Asset Action Perf %
MYGN Sell All 2.3%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
MYGN Myriad Genetics, Inc. Buy 19.19% 0.26%
The percentage of cash held in the portfolio is: 80.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
JBSS Sell All -2.12%
TVTX Sell All 33.75%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
JBSS John B. Sanfilippo & Son, Inc. Buy 18.18% 0.66%
TVTX Travere Therapeutics, Inc. Buy 20.66% 14.37%
MYGN Myriad Genetics, Inc. Buy 19.72% 0%
The percentage of cash held in the portfolio is: 41.44%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
WES Sell All -2.13%
MBUU Sell All -0.47%
TSLA Sell All -8.45%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
WES Western Midstream Partners, LP Buy 19.9% -1.94%
MBUU Malibu Boats, Inc. Buy 19.96% -1.65%
JBSS John B. Sanfilippo & Son, Inc. Buy 18.25% 0.64%
TVTX Travere Therapeutics, Inc. Buy 18.76% 3.44%
TSLA Tesla, Inc. Buy 21.15% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TSLA
Assets Removed
Asset Action Perf %
GME Sell All 4.09%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
GME GameStop Corp. Buy 21.8% 7.58%
WES Western Midstream Partners, LP Buy 19.93% -1.58%
MBUU Malibu Boats, Inc. Buy 20.08% -0.85%
JBSS John B. Sanfilippo & Son, Inc. Buy 18.1% 0%
TVTX Travere Therapeutics, Inc. Buy 18.1% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • JBSS
  • TVTX
Assets Removed
Asset Action Perf %
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 17.22% 0.35%
GME GameStop Corp. Buy 21.65% 8.88%
WES Western Midstream Partners, LP Buy 19.87% 0%
MBUU Malibu Boats, Inc. Buy 19.87% 0%
The percentage of cash held in the portfolio is: 21.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDW Sell All NA
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings